Introduction to PKD: What should I know about PKD?

Newly Diagnosed
Back to Search
November 17, 2022
This educational session will provide an overview of PKD and its impact. Topics include the different forms of PKD, available treatments and how to manage the disease.

Learning objectives

Describe the different forms of PKD, how PKD develops, and the genetic reasons it happens.

Describe PKD complications and the treatments used to control symptoms, slow the growth of cysts, and help with kidney function.

Discuss lifestyle choices and options that may slow PKD symptoms.

Speakers

Franz Winklhofer, MD
Franz Winklhofer, MD

Dr. Franz Winklhofer is certified by the American Board of Internal Medicine with a subcertification in nephrology. He completed a fellowship at the University of Kansas Medical Center. He earned his medical degree from the University of Kansas School of Medicine and completed his residency at the University of Kansas Medical Center. Dr. Winklhofer is dedicated to the delivery of quality patient care for adult kidney diseases. He is equally interested in the management of autosomal dominant polycystic kidney disease.

Ashima Gulati, MD, PhD
Ashima Gulati, MD, PhD

Ashima Gulati, MD, PhD, is a pediatric nephrologist with research interest in inherited kidney diseases with a particular focus on polycystic kidney disease. Dr. Gulati trained at the Yale School of Medicine where she also completed a PhD in Investigative Medicine. Her research focuses on human exome based investigation of genetic kidney diseases and using mouse and zebrafish as disease models for investigating vascular complications in autosomal dominant polycystic kidney disease. Dr. Gulati’s clinical interests include integration of genetic knowledge to improve the well-being of children with polycystic and inherited kidney diseases.

Related Resources

ARPKD EL-PFDD 2023

ARPKD EL-PFDD 2023

What to Expect from the ARPKD EL-PFDD Meeting On August 29, 2023 the PKD Foundation will hold its first ever Externally Led Patient-focused Drug Development (EL-PFDD) Meeting on Autosomal Recessive PKD (ARPKD) and Congenital Hepatic Fibrosis (CHF). Should you attend the meeting? What should you...

ADPKD Registry Annual Report 2022

ADPKD Registry Annual Report 2022

The PKDF Research team is excited to expand the features available in the ADPKD Registry in summer 2023. This project has been carefully planned and executed with our patients at the center. The last few years have been spent building the largest ADPKD patient-reported outcomes dataset.